| Not Yet Recruiting | A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myel Acute Myeloid Leukemia (AML) | Phase 1 / Phase 2 | 2027-12-01 |
| Not Yet Recruiting | A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Fro Pediatric Acute Leukemia | Phase 1 | 2027-12-01 |
| Not Yet Recruiting | Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodep Hematological Malignancies | Phase 2 | 2027-02-28 |
| Not Yet Recruiting | Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Adenoid Cystic Carcinoma | Phase 2 | 2026-12-28 |
| Not Yet Recruiting | Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma Aft Glioma | Phase 1 | 2026-12-01 |
| Not Yet Recruiting | A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma Metastatic Olfactory Neuroblastoma | Phase 2 | 2026-10-01 |
| Not Yet Recruiting | Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer Prostate Carcinoma | N/A | 2026-10-01 |
| Not Yet Recruiting | Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer Anaplastic Thyroid Cancer | Phase 2 | 2026-09-30 |
| Not Yet Recruiting | Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Resid Phase 2 Study, Blinatumomab, Acute Lymphoblastic Leukemia | Phase 2 | 2026-09-27 |
| Not Yet Recruiting | Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Phase 2, Sacituzumab Tirumotecan, Refractory Metastatic | Phase 2 | 2026-09-25 |
| Not Yet Recruiting | Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening Evaluating, Intermittent Fasting, Pancreatic Cancer | N/A | 2026-09-17 |
| Not Yet Recruiting | Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study Lymphatic Reconstruction, Lymphadenectomy | N/A | 2026-09-06 |
| Not Yet Recruiting | Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatell Phase 1, SAR445877, FOlfox6 | Phase 1 | 2026-09-03 |
| Not Yet Recruiting | Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML AML | Phase 1 / Phase 2 | 2026-09-01 |
| Not Yet Recruiting | A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotocl Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2026-09-01 |
| Not Yet Recruiting | Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For Th Gastric Cancer, Metastatic | Phase 1 / Phase 2 | 2026-09-01 |
| Not Yet Recruiting | PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimuma Melanoma | Phase 2 | 2026-09-01 |
| Not Yet Recruiting | A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adul T-cell Acute Lymphoblastic Leukemia, Lymphoma | Phase 1 | 2026-09-01 |
| Not Yet Recruiting | Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Ex Melanoma | Phase 1 | 2026-08-31 |
| Not Yet Recruiting | Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Lymphoid, Hodgkin Lymphoma | Phase 1 | 2026-08-31 |
| Not Yet Recruiting | Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2026-08-31 |
| Not Yet Recruiting | Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer | Phase 2 | 2026-08-31 |
| Not Yet Recruiting | Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells Fo Leptomeningeal Melanoma | Phase 1 | 2026-08-31 |
| Not Yet Recruiting | A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric a Soft Tissue Sarcomas | Phase 1 | 2026-08-31 |
| Not Yet Recruiting | Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center Metastatic Malignant Solid Neoplasm | — | 2026-08-30 |
| Not Yet Recruiting | Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphi Phase II Clinical Trial, Blinatumomab, Olverembatinib | Phase 2 | 2026-08-27 |
| Not Yet Recruiting | A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Dia Intracranial Venous Blood, Brain Cancers, Liquid Biopsy | — | 2026-08-19 |
| Not Yet Recruiting | A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed Phase I, FLAG Chemotherapy, Lisaftoclax | Phase 1 | 2026-08-17 |
| Not Yet Recruiting | PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor Tumor, Liver | N/A | 2026-08-01 |
| Not Yet Recruiting | Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Colorectal Cancer, Peritoneal Metastases, Carcinomatosis | Phase 1 / Phase 2 | 2026-07-29 |
| Not Yet Recruiting | Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease Leptomeningeal Disease | N/A | 2026-07-22 |
| Not Yet Recruiting | Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: Communication Skills, Professionalism, Randomized Controlled Trial | N/A | 2026-07-15 |
| Not Yet Recruiting | Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial Non-small Cell Lung Cancer | Phase 1 | 2026-07-01 |
| Not Yet Recruiting | Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2026-07-01 |
| Not Yet Recruiting | A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses Laryngectomy | N/A | 2026-07-01 |
| Not Yet Recruiting | ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer Dynamic Tumor Resistance, Metastatic Colorectal Cancer | EARLY_Phase 1 | 2026-06-10 |
| Not Yet Recruiting | Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer Phase IB, Avutometinib, RAS Pathway | Phase 1 | 2026-06-03 |
| Recruiting | Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma Phase 2, Zanzalintinib, Pembrolizumab | Phase 2 | 2026-06-02 |
| Not Yet Recruiting | Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma Large B-cell Lymphoma | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or R Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2026-06-01 |
| Not Yet Recruiting | Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma Phase II, Sacituzumab, Tirumotecan | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention Communication, Informed Decision-making | Phase 3 | 2026-06-01 |
| Not Yet Recruiting | Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Im Cervical Cancer, HIV | N/A | 2026-06-01 |
| Not Yet Recruiting | Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocy T-cell Prolymphocytic Leukemia, Refractory T-Cell Prolymphocytic Leukemia | Phase 1 / Phase 2 | 2026-06-01 |
| Recruiting | A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer Phase 2 Study, BMS-986504, MTAP-deleted Pancreatic Cancer | Phase 2 | 2026-05-18 |
| Not Yet Recruiting | A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Blinatumomab, Revumenib, Lymphoblastic Leukemia | Phase 1 | 2026-05-18 |
| Not Yet Recruiting | NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy Psilocybin, Neuropathy | Phase 2 | 2026-05-04 |
| Not Yet Recruiting | Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients Chronic Myeloid Leukemia | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinar Pediatric Cancer | N/A | 2026-04-30 |
| Not Yet Recruiting | Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules Thyroid Nodules, Pulsed Field Ablation | — | 2026-04-26 |
| Not Yet Recruiting | Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Stu Checkpoint Inhibitor, Pilot Study, Diabetes Melletus | N/A | 2026-04-14 |
| Recruiting | The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support Neuroendocrine Cervical Cancer, Patient Support | — | 2026-04-13 |
| Withdrawn | Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Molecular Surveillance, Breast Cancer, ctDNA | — | 2026-04-09 |
| Recruiting | Radiofrequency Ablation For Recurrent Parathyroid Carcinoma Recurrent Parathyroid Carcinoma | N/A | 2026-04-09 |
| Recruiting | DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis Neurofibromas, MPNST | — | 2026-04-02 |
| Recruiting | Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Pati Phase 2 Study, MCL, BTKi | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Clear Cell Renal Cell Carcinoma | Phase 1 | 2026-03-31 |
| Recruiting | A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Mu Phase 2, Radiotherapy-Induced Immune Priming, Elranatamab | Phase 2 | 2026-03-31 |
| Recruiting | Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for In Lung Cancer | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | Magnetic Sentinel Lymph Node Mapping in Gastric Cancer Gastric Adenocarcinoma | Phase 1 | 2026-03-31 |
| Recruiting | Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marr Lu-177 PSMA | N/A | 2026-03-30 |
| Recruiting | NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer Locally-Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2026-03-27 |
| Recruiting | A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) Phase 1b, HC-7366, SHARK | Phase 1 | 2026-03-24 |
| Not Yet Recruiting | Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer Metastatic Breast Cancer | N/A | 2026-02-28 |
| Withdrawn | Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology Prostate Cancer | Phase 2 | 2026-02-28 |
| Not Yet Recruiting | Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Large B-cell Lymphoma, Hodgkin Lymphoma | Phase 2 | 2026-02-28 |
| Recruiting | Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients Cancer | Phase 2 | 2026-02-24 |
| Recruiting | Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC Aerobic Exercise, Early Stage Triple Negative Breast Cancer | N/A | 2026-02-23 |
| Recruiting | Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms Neoplasms | Phase 1 | 2026-02-18 |
| Recruiting | Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System Levonorgestrel, Intrauterine Systems, Prevention | — | 2026-02-12 |
| Recruiting | Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss Advanced Cancer, Solid Tumor | Phase 1 | 2026-02-12 |
| Recruiting | Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma Thyroid Carcinoma | N/A | 2026-02-11 |
| Suspended | Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Can Colorectal Cancer, Regorafenib, High Risk Patients | Phase 2 | 2026-02-11 |
| Recruiting | Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chroni Chronic Graft Versus Host Disease | — | 2026-02-09 |
| Not Yet Recruiting | iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prosta Prostate Cancer | N/A | 2026-01-31 |
| Not Yet Recruiting | Facilitators and Barriers to Cancer Treatment Among Texas Residents Cancer | N/A | 2026-01-31 |
| Recruiting | A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensi B-cell Acute Lymphoblastic Leukemia | Phase 2 | 2026-01-30 |
| Not Yet Recruiting | Adoption of Audio Recording in the Outpatient Supportive Care Center Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm | — | 2026-01-30 |
| Recruiting | Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Care Family Centered, Black Ethnicity, Prostate Cancer Survivors | N/A | 2026-01-13 |
| Recruiting | Decoupling Immunotherapy Toxicity and Cancer Response Tumor, Cardiovascular | — | 2026-01-09 |
| Recruiting | A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Qualit Cancer | N/A | 2026-01-08 |
| Recruiting | Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk Breast Cancer | — | 2026-01-06 |
| Recruiting | Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Thera Myelofibrosis (MF), Chronic Myelomonocytic Leukemia (CMML) | Phase 1 / Phase 2 | 2026-01-02 |
| Recruiting | Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases Brain Metastases | Phase 2 | 2026-01-01 |
| Recruiting | A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Spiritual Care, Advanced Cancer | N/A | 2025-12-22 |
| Recruiting | Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Clear Cell Renal Cell Carcinoma | Phase 2 | 2025-12-19 |
| Recruiting | CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal Psychological Distress | — | 2025-12-18 |
| Recruiting | Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longit Peripheral Neuropathy Due to Chemotherapy | EARLY_Phase 1 | 2025-12-11 |
| Recruiting | A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) Bone Sarcomas | Phase 2 | 2025-12-05 |
| Not Yet Recruiting | Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcin Active Surveillance, Clear Cell Renal Cell Carcinoma | Phase 2 | 2025-12-03 |
| Recruiting | A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 | 2025-12-02 |
| Recruiting | A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Dise Pilot Study, PET/CT Imaging, Host Disease Manifestation | Phase 2 | 2025-11-18 |
| Recruiting | A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer Non-Small Cell Lung Cancer, ICI-refractory | Phase 2 | 2025-11-06 |
| Not Yet Recruiting | Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer Malignant Neoplasm | Phase 2 | 2025-11-05 |
| Recruiting | Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord B Head and Neck Cancer | Phase 1 | 2025-11-04 |
| Not Yet Recruiting | Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid M Colon Cancer | — | 2025-10-31 |
| Withdrawn | A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Re Rectal Cancer, Rectal Cancer Recurrent | Phase 2 | 2025-10-27 |
| Enrolling By Invitation | Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer Prostate Cancer | N/A | 2025-10-24 |
| Recruiting | IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-po Metastatic Endocrine Refractory, Triple Negative Invasive Lobular Carcinoma | Phase 2 | 2025-10-22 |
| Recruiting | Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagno Chronic Myeloid Leukemia | Phase 2 | 2025-10-13 |
| Suspended | The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postope Breast Cancer | — | 2025-10-09 |
| Active Not Recruiting | Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma | Phase 2 | 2025-10-09 |
| Recruiting | Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures Pulmonary | — | 2025-10-08 |
| Recruiting | A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in P Multiple Actinic Keratoses | Phase 3 | 2025-10-06 |
| Recruiting | Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine Psychotherapy, Integrative Medicine | N/A | 2025-10-03 |
| Recruiting | Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS Uterine Leiomyosarcoma | Phase 2 | 2025-10-02 |
| Terminated | Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment Breast Cancer Survivor, Pregnant Women, Quality of Lifte | — | 2025-10-01 |
| Not Yet Recruiting | Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project Mucormycosis | — | 2025-09-30 |
| Recruiting | T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Metastatic Soft-tissue Sarcoma | Phase 1 | 2025-09-29 |
| Recruiting | Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Trea Clear Cell Carcinoma, Phase 1, Growth Factor | Phase 1 | 2025-09-25 |
| Recruiting | Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Progr Lung Cancer | — | 2025-09-25 |
| Recruiting | A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Ped T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic Lymphoma | Phase 2 | 2025-09-25 |
| Withdrawn | Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With An Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2025-09-23 |
| Recruiting | Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) Metastatic Triple-Negative Breast Cancer | Phase 1 / Phase 2 | 2025-09-19 |
| Recruiting | Feasibility Testing of a Dyadic Exercise Program for Patients Undergoing Thoracic Radiotherapy and Their Famil Non-small Cell Lung Cancer | N/A | 2025-09-18 |
| Recruiting | A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cance Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer | Phase 2 | 2025-09-18 |
| Recruiting | Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodenta Orodental Injury | — | 2025-09-15 |
| Recruiting | Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Har Targeted Therapy, IDH1-Mutated Malignancies, Mutations | Phase 2 | 2025-09-12 |
| Recruiting | SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-oper Soft Tissue Sarcoma | Phase 2 | 2025-09-11 |
| Recruiting | Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Ef Cancer, Fatigue, Brain Tumor Adult | N/A | 2025-09-09 |
| Withdrawn | A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-l Colorectal Cancer | Phase 1 / Phase 2 | 2025-09-03 |
| Recruiting | A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 ( Myeloid Malignancies | Phase 1 / Phase 2 | 2025-09-03 |
| Recruiting | Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas Bone Sarcomas, Financial Toxicity | — | 2025-09-02 |
| Recruiting | Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplanta Physical Activity, Sleep, Allogenic Hematopoietic Cell Transplant | — | 2025-09-02 |
| Recruiting | Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer Cancer | — | 2025-08-29 |
| Recruiting | Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Interv Breast Cancer | N/A | 2025-08-27 |
| Recruiting | Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Pati Acute Lymphocytic Leukemia (ALL) | Phase 2 | 2025-08-26 |
| Recruiting | Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Breast Cancer | Phase 2 | 2025-08-19 |
| Recruiting | Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation | — | 2025-08-18 |
| Recruiting | A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasi Spinal Metastasis | Phase 1 | 2025-08-18 |
| Recruiting | Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer Medullary Thyroid Cancer (MTC), Cultural Adaptation | — | 2025-08-15 |
| Suspended | Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab Microsatellite-stable Colorectal Cancer, Standard of Care, Nivolumab | Phase 2 | 2025-08-15 |
| Recruiting | A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) Breast Cancer | Phase 1 | 2025-08-13 |
| Recruiting | Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomi Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer | Phase 2 | 2025-08-08 |
| Suspended | 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cyt Metastatic Castration Resistant Prostate Cancer, Cytopenia, Anemia | Phase 2 | 2025-08-03 |
| Active Not Recruiting | Opiophobia in Adults With Advanced Cancer Cancer | — | 2025-08-01 |
| Withdrawn | A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating Wit Refractory Acute Leukemia, Relapsed Acute Leukemia | Phase 1 | 2025-07-31 |
| Withdrawn | STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescima Lung Squamous Cell Carcinoma, Anti-PD1/PDL1 Antibody | Phase 2 | 2025-07-28 |
| Recruiting | Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastati Metastatic Colorectal Cancer | Phase 2 | 2025-07-28 |
| Recruiting | Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery Neoadjuvant Treatment, Thyroid Cancer | Phase 2 | 2025-07-22 |
| Recruiting | A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyc AML | Phase 2 | 2025-07-22 |
| Recruiting | Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer Advanced Cancer | N/A | 2025-07-21 |
| Recruiting | EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Breast Cancer | Phase 2 | 2025-07-17 |
| Recruiting | Interactive Design of Patient-Specific Molds for Tissue Shaping Mastectomy | N/A | 2025-07-17 |
| Recruiting | Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patient Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia (SLL) | Phase 2 | 2025-07-15 |
| Recruiting | Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study. Peripheral Neuropathy Due to Chemotherapy | N/A | 2025-07-14 |
| Recruiting | Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Pr Advanced Cancer | N/A | 2025-07-10 |
| Recruiting | Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2025-07-10 |
| Recruiting | A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC Prostate Cancer | Phase 1 | 2025-07-09 |
| Recruiting | Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors Solid Tumors | Phase 2 | 2025-07-02 |
| Recruiting | Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Canc Diabetes, Prostate Cancer | EARLY_Phase 1 | 2025-07-02 |
| Recruiting | Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma Ivonescimab, Clear Cell Renal Carcinoma | Phase 2 | 2025-07-02 |
| Withdrawn | Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-neg Squamous Cell Carcinoma of Head and Neck | EARLY_Phase 1 | 2025-06-20 |
| Recruiting | HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patient Advanced Intrahepatic Cholangiocarcinoma | Phase 2 | 2025-06-10 |
| Withdrawn | A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma B-cell Lymphoma | Phase 2 | 2025-06-06 |
| Recruiting | Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer Ovarian Cancer | N/A | 2025-06-06 |
| Withdrawn | Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases Renal Cell Carcinoma, Brain Metastasis | Phase 2 | 2025-06-04 |
| Recruiting | Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer Prostate Cancer | Phase 2 | 2025-06-03 |
| Recruiting | Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized DIGEST, Evidence Based Measurement, Dysphagia | N/A | 2025-06-01 |
| Recruiting | TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survi Depression, Anxiety, Cancer | Phase 2 | 2025-05-23 |
| Recruiting | Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of Non-Small Cell Lung Cancer | N/A | 2025-05-14 |
| Recruiting | Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomi Acute Myeloid Leukemia (AML) | Phase 2 | 2025-05-08 |
| Recruiting | Multi-center MRD Registry for Inflammatory Breast Cancer Breast Cancer | — | 2025-05-05 |
| Not Yet Recruiting | Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy Melanoma | Phase 1 / Phase 2 | 2025-05-01 |
| Recruiting | Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention Liver Cancer | — | 2025-05-01 |
| Withdrawn | Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC Squamous Cell Carcinoma | Phase 2 | 2025-05-01 |
| Active Not Recruiting | Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies Hematological Malignancies | N/A | 2025-05-01 |
| Recruiting | Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial Peripheral Neuropathy Due to Chemotherapy | N/A | 2025-04-18 |
| Recruiting | Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Pa Colorectal Cancer | — | 2025-04-18 |
| Active Not Recruiting | Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Maligna Advanced Solid Malignancies | Phase 1 | 2025-04-13 |
| Active Not Recruiting | A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD- Cancer | Phase 2 | 2025-04-11 |
| Recruiting | Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full- Dietary Monitoring | N/A | 2025-04-08 |
| Recruiting | Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Amon Cancer | N/A | 2025-03-31 |
| Recruiting | CPRIT: Patient Adherence to Lung Cancer Screening Lung Cancer Screening | — | 2025-03-21 |
| Recruiting | A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-lin Renal Cell Carcinoma, Clear Cell | Phase 2 | 2025-03-20 |
| Recruiting | Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomar Occupational Stress | — | 2025-03-17 |
| Recruiting | A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lym Cutaneous T-Cell Lymphoma | Phase 2 | 2025-03-10 |
| Suspended | Supporting Informed Decision Making About Multi-cancer Early Detection Testing Multi-cancer Early Detection | — | 2025-03-07 |
| Recruiting | A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab Acute Myeloid Leukemia | Phase 1 | 2025-03-07 |
| Recruiting | Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors Solid Tumor | Phase 1 | 2025-03-05 |
| Recruiting | A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome(MDS), Acute Myelogenous Leukemia (AML) | Phase 1 / Phase 2 | 2025-03-05 |
| Recruiting | Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Hematologic Malignancies | Phase 2 | 2025-03-03 |
| Recruiting | Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesi Premalignant Lesion | Phase 2 | 2025-02-27 |
| Recruiting | Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants Phase 1, Recurrent Melanoma, Refractory Melanoma | Phase 1 | 2025-02-25 |
| Recruiting | Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Re Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma | N/A | 2025-02-25 |
| Recruiting | Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Ce Advanced Colorectal Cancer | Phase 2 | 2025-02-24 |
| Recruiting | A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Managem Peripheral T Cell Lymphoma | Phase 2 | 2025-02-21 |
| Recruiting | Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry Thoracic Tumors | — | 2025-02-19 |
| Recruiting | Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments Smoking | N/A | 2025-02-19 |
| Recruiting | A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Refractory Acute Leukemia, Relapsed Acute Leukemia, Undifferentiated Leukemia | Phase 1 | 2025-02-18 |
| Recruiting | Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicompone HR-HPV Testing | N/A | 2025-02-17 |
| Recruiting | Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia Malignant Solid Tumors | Phase 2 | 2025-02-14 |
| Recruiting | EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase Brain Metastases | Phase 2 | 2025-02-14 |
| Recruiting | Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Lymphedema, Fibrosis | Phase 2 | 2025-02-13 |
| Recruiting | Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2025-02-12 |
| Completed | The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Fait Prostate Cancer Screening | N/A | 2025-02-06 |
| Withdrawn | Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Pathway Mutant Myelodysplastic Syndromes, Myelodysplastic Neoplasm, Myeloproliferative Neoplasm | Phase 1 / Phase 2 | 2025-01-31 |
| Recruiting | A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malig Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | 2025-01-30 |
| Recruiting | A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma Glioblastoma | Phase 1 / Phase 2 | 2025-01-30 |
| Active Not Recruiting | GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patient Mantle Cell Lymphoma | Phase 2 | 2025-01-30 |
| Recruiting | A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutat Chronic Myelomonocytic Leukemia, Advanced Myeloproliferative Neoplasms, IDH1-mutated Higher-Risk Myelodysplastic Syndromes | Phase 2 | 2025-01-28 |
| Recruiting | CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Met Metastatic Biliary Tract Cancer | Phase 1 / Phase 2 | 2025-01-22 |
| Recruiting | Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve F Cancer, Head and Neck Cancer | N/A | 2025-01-13 |
| Active Not Recruiting | Impact of Diaphragmatic Breathing Coaching on Deep Inspiration Breath Hold Reproducibility and Organ Protectio Breathing, Mouth | N/A | 2025-01-08 |
| Recruiting | Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain Hypophysectomy | Phase 1 | 2025-01-06 |
| Recruiting | A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies | Phase 2 | 2024-12-31 |
| Active Not Recruiting | ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive AML | Phase 1 / Phase 2 | 2024-12-30 |
| Recruiting | A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relap Refractory Acute Leukemia, Pediatric Relapsed | Phase 1 | 2024-12-27 |
| Recruiting | A Randomized Controlled Trial to Assess the Impact of Live and Recorded Music-Based Interventions on Pre-opera Stress, Pain | N/A | 2024-12-19 |
| Active Not Recruiting | ACT-Together (Acting on Cancer Testing-Together) Cancer | N/A | 2024-12-18 |
| Recruiting | A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Metastatic Cancer | N/A | 2024-12-18 |
| Recruiting | Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure Heart Failure | — | 2024-12-16 |
| Recruiting | Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Canc Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8 | N/A | 2024-12-16 |
| Recruiting | Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell Cell Therapy | Phase 2 | 2024-12-12 |
| Withdrawn | Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cance Non-small Cell Lung Cancer | Phase 2 | 2024-12-11 |
| Recruiting | A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma Lymphoma | Phase 2 | 2024-12-11 |
| Recruiting | A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Signifi Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Clonal Cytopenia of Undetermined Significance | Phase 2 | 2024-12-10 |
| Recruiting | Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventi Thyroid Cancer | — | 2024-12-05 |
| Recruiting | Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures Needle Biopsy | N/A | 2024-12-05 |
| Recruiting | Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment Colorectal Cancer | Phase 2 | 2024-12-04 |
| Recruiting | Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in C Colorectal Cancer, Minimal Residual Disease | Phase 1 | 2024-12-02 |
| Recruiting | Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma | Phase 2 | 2024-12-02 |
| Withdrawn | AIM4 AI and Mechanistic Modeling in Molecular Medicine Molecular Medicine | — | 2024-11-30 |
| Recruiting | Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study Tumor | Phase 2 | 2024-11-26 |
| Recruiting | A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy Thyroid Lobectomy | Phase 2 | 2024-11-26 |
| Recruiting | A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encod Select Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-11-21 |
| Recruiting | Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Rando Health Options, Strategic Care Planning | — | 2024-11-21 |
| Recruiting | Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study Impulse Control Disorder | Phase 1 | 2024-11-21 |
| Recruiting | Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma Locally Recurrent Oral Cavity Squamous Cell Carcinoma | Phase 2 | 2024-11-21 |
| Recruiting | The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hemato Cytomegalovirus Cell Mediated Immunity, Hematopoietic Cell Transplant | N/A | 2024-11-20 |
| Recruiting | Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cho Advanced Cholangiocarcinoma, FGFR2 Fusion | Phase 1 / Phase 2 | 2024-11-19 |
| Recruiting | Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Co Spinal Cord, Metastatic Epidural, Spine Stereotactic | Phase 2 | 2024-11-11 |
| Recruiting | A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pse Brain Metastases | N/A | 2024-11-07 |
| Withdrawn | A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma Metastatic Olfactory Neuroblastoma, Recurrent Olfactory Neuroblastoma | Phase 2 | 2024-11-01 |
| Recruiting | Clinical and Molecular Features of Oral Premalignancy and Oral Cancer Oral Cancer | — | 2024-10-31 |
| Recruiting | Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Meta Solid Tumor | Phase 1 | 2024-10-31 |
| Recruiting | Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Ph Pancreas Cancer, Oligometastatic | Phase 3 | 2024-10-23 |
| Withdrawn | Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease Leukemia | Phase 1 | 2024-10-21 |
| Recruiting | Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breas Architectural Distortions, Breast Tomosynthesis | — | 2024-10-18 |
| Recruiting | Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) Melanoma (Skin Cancer), Breast Cancer, Brain Metastasases | Phase 1 | 2024-10-15 |
| Recruiting | Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE) Advanced Bladder Cancer | Phase 1 / Phase 2 | 2024-10-10 |
| Recruiting | Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Mal SMARCB1-Deficient Malignancies | Phase 2 | 2024-10-09 |
| Recruiting | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly Splenomegaly, Myelofibrosis | Phase 2 | 2024-10-01 |
| Withdrawn | Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis Advanced Solid Tumor, Carcinomatosis | Phase 1 | 2024-09-30 |
| Recruiting | Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial. Lymphedema | Phase 2 | 2024-09-24 |
| Recruiting | A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2024-09-23 |
| Active Not Recruiting | Opiophobia in Postsurgical Adults With Cancer Opiophobia | — | 2024-09-16 |
| Recruiting | Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Res Melanoma | Phase 2 | 2024-09-16 |
| Withdrawn | A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients W Myelofibrosis | Phase 2 | 2024-09-11 |
| Recruiting | A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immun Arthritis, Polymyalgia Rheumatica, Immune Checkpoint Inhibitors | — | 2024-09-11 |
| Recruiting | PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality Androgen Axis Suppression, Prostatectomy, Prostate Cancer | Phase 3 | 2024-09-10 |
| Recruiting | Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord Spinal Cord | N/A | 2024-09-04 |
| Recruiting | 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer Esophageal Cancer | Phase 1 | 2024-09-04 |
| Recruiting | Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Un Unresectable Melanoma | Phase 2 | 2024-09-01 |
| Recruiting | Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutaside Mutant IDH1 Inhibitor Olutasidenib | Phase 1 / Phase 2 | 2024-08-29 |
| Recruiting | A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harbor Metastatic Colorectal Cancer, KRAS G12C Mutations | Phase 1 / Phase 2 | 2024-08-28 |
| Recruiting | Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment Pulmonary, Pneumonia, Hematopoietic System--Cancer | — | 2024-08-14 |
| Recruiting | A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tiss Leiomyosarcoma, Soft-tissue Sarcomas | Phase 1 | 2024-08-14 |
| Recruiting | Harmony & Health: A Culturally Adapted Mindbody Intervention to Reduce Sitting Time and Improve Psychosocial W Psychosocial | N/A | 2024-08-14 |
| Terminated | Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human E Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular Carcinoma | Phase 2 | 2024-08-08 |
| Active Not Recruiting | A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in P Metastatic Renal Cell Carcinoma | Phase 2 | 2024-08-07 |
| Recruiting | A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leuke Advanced Chronic Myeloid Leukemia, Philadelphia Chromosome-Positive Acute Myeloid Leukemia | Phase 1 | 2024-08-06 |
| Recruiting | Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Pos Philadelphia Chromosome-Positive, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2024-08-05 |
| Recruiting | Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-Essential Thrombocytosis Myelofibrosis | Phase 1 / Phase 2 | 2024-08-01 |
| Recruiting | Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Aut Autoimmune Disorders, Systemic Sclerosis, Systemic Lupus Erythematosus | Phase 1 / Phase 2 | 2024-07-31 |
| Withdrawn | Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Open Recurrent Glioblastoma | Phase 2 | 2024-07-30 |
| Recruiting | Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV) Human Papillomavirus | — | 2024-07-23 |
| Recruiting | Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With Hi Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging | Phase 2 | 2024-07-17 |
| Recruiting | Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy Chemotherapy-induced Peripheral Neuropathy | — | 2024-07-16 |
| Recruiting | Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a P Cancer, Occupational Therapy | — | 2024-07-12 |
| Recruiting | Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation i Relapsed/Refractory, B-cell Acute Lymphocytic Leukemia | Phase 1 / Phase 2 | 2024-07-11 |
| Recruiting | Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Thera Rectal Adenocarcinoma | Phase 2 | 2024-07-10 |
| Recruiting | Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA) Mesonephric-like Adenocarcinoma | — | 2024-07-10 |
| Recruiting | A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia Cytopenia | Phase 2 | 2024-07-05 |
| Withdrawn | A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treat Allogeneic Stem Cell Transplantation | Phase 2 | 2024-07-01 |
| Recruiting | PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Pro Advanced Prostate Cancer | Phase 1 | 2024-06-27 |
| Recruiting | Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodep Lymphodepleting Chemotherapy, Myeloid Malignancies | Phase 1 / Phase 2 | 2024-06-26 |
| Recruiting | Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women Endometrial Cancer | — | 2024-06-25 |
| Recruiting | Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder Familial Platelet Disorder, Hematopoietic | Phase 2 | 2024-06-20 |
| Active Not Recruiting | Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 1 Gastrointestinal Stromal Tumors | Phase 2 | 2024-06-18 |
| Active Not Recruiting | PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-06-18 |
| Recruiting | Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Soci Transplant and Cell Therapy | — | 2024-06-17 |
| Recruiting | Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology Dyspnea | Phase 2 / Phase 3 | 2024-06-11 |
| Recruiting | Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effec Radiation | — | 2024-06-10 |
| Recruiting | A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease | Phase 2 / Phase 3 | 2024-06-06 |
| Recruiting | A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes Leukemia, HOX Gene | Phase 2 | 2024-06-04 |
| Recruiting | Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain M Brain Malignancies, Pseudoprogression | Phase 1 | 2024-06-04 |
| Recruiting | Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation Allogeneic Transplantation | — | 2024-05-31 |
| Recruiting | Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Mantle Cell Lymphoma | Phase 2 | 2024-05-29 |
| Recruiting | Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carbopla Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer | Phase 2 | 2024-05-29 |
| Recruiting | A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer Cancer | N/A | 2024-05-22 |
| Recruiting | A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2024-05-22 |
| Recruiting | The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cance Colon Cancer | Phase 2 | 2024-05-20 |
| Recruiting | Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis RUNX1 Familial Platelet Disorder | Phase 1 | 2024-05-20 |
| Recruiting | Phase I Study of HC-7366 for Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2024-05-20 |
| Recruiting | Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Departme Lung Cancer, Gastrointestinal Cancer | N/A | 2024-05-14 |
| Recruiting | A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients W B Cell Lymphoma | Phase 2 | 2024-05-07 |
| Recruiting | Understanding Patient Experience Among Asians at MD Anderson Cancer | — | 2024-04-24 |
| Recruiting | Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphod Hematological Malignancy | Phase 1 / Phase 2 | 2024-04-22 |
| Recruiting | Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-a Oropharyngeal Neoplasms, Robotic Surgery and/or Radiotherapy, Lymphoscintigraphy | Phase 2 | 2024-04-19 |
| Recruiting | Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy Depression, Anxiety, Psilocybin-Assisted Psychotherapy, Advanced Cancer | Phase 2 | 2024-04-16 |
| Suspended | Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging Ovarian Cancer | Phase 1 | 2024-04-12 |
| Active Not Recruiting | Evaluation of Hereditary Cancer Educational Videos Hereditary Cancer | — | 2024-04-05 |
| Recruiting | Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Misuse, Opioid | Phase 3 | 2024-04-02 |
| Active Not Recruiting | NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial Prostate Cancer | Phase 1 / Phase 2 | 2024-03-29 |
| Active Not Recruiting | 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Rando Intra-abdominal Cancer | Phase 2 | 2024-03-27 |
| Recruiting | Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 Synovial Sarcoma, Myxoid/Round Cell Liposarcoma | Phase 1 | 2024-03-27 |
| Recruiting | Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospecti Oncologic Complications and Emergencies | N/A | 2024-03-27 |
| Active Not Recruiting | Multi-site Feasibility and Acceptability of a Faith-based Mind-body Intervention for Black Adults Psychosocial, Mind-body | N/A | 2024-03-26 |
| Recruiting | A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Hav Hypoactive Delirium | — | 2024-03-25 |
| Withdrawn | Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma Angiosarcoma | Phase 1 | 2024-03-22 |
| Active Not Recruiting | Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Follicular Lymphoma, Tumor | Phase 2 | 2024-03-15 |
| Recruiting | Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 | EARLY_Phase 1 | 2024-03-13 |
| Recruiting | A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, a Acute Myeloid Leukemia | Phase 1 | 2024-03-07 |
| Recruiting | A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS) Myelodysplastic Syndromes | Phase 2 | 2024-03-01 |
| Active Not Recruiting | Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune ICB-refractory Melanoma | Phase 2 | 2024-03-01 |
| Active Not Recruiting | 3D Printed Breast Models in the Surgical Management of Breast Cancer Breast Cancer | N/A | 2024-02-29 |
| Recruiting | Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggr Prostate Cancer | Phase 1 / Phase 2 | 2024-02-29 |
| Recruiting | Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropath Peripheral Nerve Stimulation, Chemotherapy-induced Peripheral Neuropathy | N/A | 2024-02-22 |
| Recruiting | Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therap Lymphoma | Phase 2 | 2024-02-19 |
| Recruiting | Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers Metastatic Cancers, Fatigue | Phase 2 / Phase 3 | 2024-02-16 |
| Active Not Recruiting | Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibi Smoking | N/A | 2024-02-15 |
| Withdrawn | A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2024-02-08 |
| Recruiting | A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity Neurotoxicity | — | 2024-02-08 |
| Recruiting | Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia Af Pneumococcal Vaccine, Esophageal Cancer, Lymphopenia | — | 2024-02-05 |
| Recruiting | STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy Immune Checkpoint Therapy | N/A | 2024-02-02 |
| Recruiting | Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leu Chronic Myeloid Leukemia | Phase 2 | 2024-01-31 |
| Active Not Recruiting | A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 G Advanced Solid Tumor, Melanoma, Lung Neoplasms | Phase 1 / Phase 2 | 2024-01-31 |
| Recruiting | A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma Metastatic Appendiceal Adenocarcinoma, Intraperitoneal Paclitaxel | Phase 1 / Phase 2 | 2024-01-30 |
| Terminated | Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib Advanced Solid Tumor, Non-small Cell Lung Cancers | Phase 1 | 2024-01-30 |
| Recruiting | Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients Multiple Myeloma | Phase 1 / Phase 2 | 2024-01-30 |
| Recruiting | A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative R Bone Metastases | Phase 3 | 2024-01-24 |
| Terminated | A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Metastatic Pancreatic Cancer | Phase 1 | 2024-01-22 |
| Recruiting | Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis Lymphomatoid Papulosis, Mycosis Fungoides | — | 2024-01-19 |
| Recruiting | Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encora Metastatic Colorectal Cancer | Phase 1 | 2024-01-18 |
| Recruiting | A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Re Cholangiocarcinoma | Phase 2 | 2024-01-16 |
| Recruiting | Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue Breast Cancer | — | 2024-01-11 |
| Recruiting | Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot St Head and Neck Squamous Cell Carcinoma | Phase 4 | 2024-01-10 |
| Recruiting | Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers Cancer | N/A | 2024-01-09 |
| Recruiting | A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Co Follicular Lymphoma | Phase 2 | 2024-01-08 |
| Recruiting | Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracy Large B-cell Lymphoma | Phase 2 | 2024-01-05 |
| Recruiting | Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2024-01-05 |
| Active Not Recruiting | Harmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Psychological | N/A | 2023-12-18 |
| Active Not Recruiting | PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic H Hodgkin Lymphoma | Phase 2 | 2023-12-14 |
| Recruiting | Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients Ovarian Cancer | Phase 2 | 2023-12-12 |
| Active Not Recruiting | Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Colon Cancer, Colorectal Cancer | Phase 1 | 2023-12-06 |
| Recruiting | A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Prostate Cancer, Radical Prostatectomy | Phase 1 / Phase 2 | 2023-12-04 |
| Recruiting | A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma, Colorectal | N/A | 2023-12-04 |
| Recruiting | Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor f Myeloma | Phase 1 / Phase 2 | 2023-11-30 |
| Terminated | Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Head Neck, Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2023-11-28 |
| Recruiting | Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 Ovarian Clear Cell Carcinoma | Phase 1 / Phase 2 | 2023-11-10 |
| Active Not Recruiting | Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neur Neuropathy;Peripheral | N/A | 2023-11-02 |
| Recruiting | A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Cancer | — | 2023-11-02 |
| Recruiting | A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (A Oligometastatic Renal Cell Carcinoma | Phase 2 | 2023-10-31 |
| Recruiting | Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer HPV | N/A | 2023-10-30 |
| Recruiting | A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML) Acute Myeloid Leukemia | Phase 1 | 2023-10-26 |
| Recruiting | Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cell Solid Tumors | Phase 1 | 2023-10-24 |
| Active Not Recruiting | BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients HPV, Oropharyngeal Cancer | Phase 2 | 2023-10-18 |
| Recruiting | Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery Breast Cancer | Phase 2 / Phase 3 | 2023-10-12 |
| Recruiting | Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma | Phase 1 / Phase 2 | 2023-10-11 |
| Terminated | A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokine Leukemia, Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 1 | 2023-10-09 |
| Recruiting | Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Stud Pelvic Metastasis | Phase 1 | 2023-10-06 |
| Active Not Recruiting | Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors Lymphoma | Phase 4 | 2023-10-06 |
| Recruiting | Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Min Liver | N/A | 2023-10-05 |
| Withdrawn | An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before Large B-cell Lymphoma, B-cell Lymphoma | Phase 2 | 2023-09-30 |
| Active Not Recruiting | Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER S Breast Carcinoma | — | 2023-09-20 |
| Recruiting | Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer Breast Carcinoma, Invasive Breast Carcinoma | — | 2023-09-15 |
| Withdrawn | Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Ch Chronic Myelomonocytic Leukemia | Phase 1 / Phase 2 | 2023-09-14 |
| Recruiting | A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Pos Gastric Adenocarcinoma, Carcinomatosis | Phase 2 | 2023-09-08 |
| Recruiting | A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Su Soft Tissue Sarcoma, Bone Sarcoma | Phase 1 | 2023-09-08 |
| Recruiting | Spanish Decision Tool for Ovarian Cancer Maintenance Therapy Ovarian Cancer | N/A | 2023-08-31 |
| Active Not Recruiting | Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pem Endometrial Cancer | Phase 2 | 2023-08-29 |
| Recruiting | Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hemat Hematopoietic Stem Cell Transplantation, Cancer | N/A | 2023-08-28 |
| Recruiting | Data Collection Protocol for Patients With Von Hippel Lindau Disease Von Hippel Lindau Disease | — | 2023-08-24 |
| Recruiting | 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Can Esophageal Carcinoma | — | 2023-08-23 |
| Recruiting | Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic C Pancreatic Cyst | Phase 1 | 2023-08-18 |
| Active Not Recruiting | A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combina Lung Cancer | Phase 1 | 2023-08-18 |
| Recruiting | Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | 2023-08-17 |
| Recruiting | Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients Multiple Myeloma | Phase 2 | 2023-08-17 |
| Recruiting | A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refr Refractory Solid Tumors | Phase 1 | 2023-08-16 |
| Recruiting | Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Inje Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain | N/A | 2023-08-10 |
| Withdrawn | A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Metastatic Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2023-08-08 |
| Withdrawn | Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment Cholangiocarcinoma, Liver Cancer | Phase 1 | 2023-08-07 |
| Recruiting | Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Ste Stem Cell | N/A | 2023-08-04 |
| Recruiting | Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Stu Lymphadenectomy | — | 2023-08-02 |
| Suspended | An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Cancer | — | 2023-08-01 |
| Recruiting | A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma Lymphoma | Phase 2 | 2023-07-28 |
| Recruiting | Health Benefits of Writing Therapy Among Asian American Cancer Survivors Cancer | N/A | 2023-07-27 |
| Recruiting | Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers Gland, Salivary Gland Cancers | Phase 2 | 2023-07-27 |
| Active Not Recruiting | Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resec Pancreatic Cancer | Phase 3 | 2023-07-18 |
| Recruiting | Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Endometrial Cancer | Phase 1 | 2023-07-17 |
| Recruiting | Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Leukemia | Phase 2 | 2023-07-14 |
| Recruiting | Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Ovarian Cancer | Phase 1 | 2023-07-12 |
| Withdrawn | A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Refractory B-cell Acute Lymphoblastic Leukemia | Phase 1 | 2023-07-05 |
| Recruiting | Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients Advanced Cancer, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2023-06-30 |
| Recruiting | 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-06-30 |
| Active Not Recruiting | A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanc Solid Tumor | Phase 1 / Phase 2 | 2023-06-21 |
| Active Not Recruiting | Reminder Messages for Lung Cancer Screening Skin Flaps, Lung Cancer | — | 2023-06-20 |
| Completed | A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperativ Neoplastic Conditions | N/A | 2023-06-19 |
| Recruiting | Precision Optical Guidance for Oral Biopsy Oral Lesions | N/A | 2023-06-15 |
| Active Not Recruiting | A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimbereli Urothelial Carcinoma, Metastatic Cancer | Phase 2 | 2023-06-13 |
| Terminated | A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brai Brain Tumor, Brain Cancer | N/A | 2023-06-05 |
| Recruiting | Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancer Brain Metastases | Phase 2 | 2023-06-02 |
| Recruiting | Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma | Phase 2 | 2023-06-02 |
| Recruiting | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testi Prostate Cancer | — | 2023-05-25 |
| Active Not Recruiting | A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resista Breast Cancer | Phase 2 | 2023-05-23 |
| Recruiting | A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Re Lymphoma | Phase 1 / Phase 2 | 2023-05-19 |
| Active Not Recruiting | HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocy Chronic Lymphocytic Leukemia | N/A | 2023-05-17 |
| Withdrawn | Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult M Colorectal Cancer, Colon Cancer, Rectum Cancer | Phase 2 | 2023-05-17 |
| Recruiting | A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Metastatic Solid Tumor, Brain Metastases | Phase 2 | 2023-05-16 |
| Recruiting | Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC Spinal Disease | Phase 2 | 2023-05-09 |
| Recruiting | Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunot Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | 2023-05-08 |
| Withdrawn | Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 1 | 2023-05-03 |
| Recruiting | Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma | Phase 1 | 2023-04-28 |
| Recruiting | A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL | Phase 2 | 2023-04-28 |
| Withdrawn | A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-i Lung Cancer, Gastro-intestinal Cancer | Phase 1 | 2023-04-25 |
| Recruiting | Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic O Locally Advanced Osteosarcoma, Metastatic Osteosarcoma, Recurrent Osteosarcoma | Phase 2 | 2023-04-25 |
| Recruiting | Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas Gliomas | EARLY_Phase 1 | 2023-04-20 |
| Active Not Recruiting | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancrea Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | Phase 2 | 2023-04-18 |
| Suspended | Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer | — | 2023-04-14 |
| Active Not Recruiting | Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer | N/A | 2023-04-14 |
| Recruiting | A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With R Lymphomas, B-cell Lymphomas | Phase 1 | 2023-04-14 |
| Active Not Recruiting | Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer Cancer | N/A | 2023-04-13 |
| Terminated | Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patient Leukemia, Lymphoblastic, Leukemia | Phase 2 | 2023-04-06 |
| Recruiting | Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally F Breast Cancer | Phase 3 | 2023-04-05 |
| Active Not Recruiting | Metformin and Nightly Fasting in Women With Early Breast Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ | Phase 2 | 2023-04-04 |
| Recruiting | Active Living After Cancer: Implementation Within Be Well Acres Homes Cancer, Fatigue | N/A | 2023-04-03 |
| Recruiting | Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma | Phase 1 / Phase 2 | 2023-03-29 |
| Recruiting | Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance Prostate Cancer | — | 2023-03-29 |
| Active Not Recruiting | EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolum Ovarian Cancer | Phase 2 | 2023-03-24 |
| Terminated | A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients Adrenocortical Carcinoma | Phase 2 | 2023-03-23 |
| Withdrawn | The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Us Opioids | — | 2023-03-23 |
| Recruiting | A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in T Cells, Colorectal Cancer, Lynch Syndrome | Phase 2 | 2023-03-21 |
| Terminated | Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Liver Cancer | Phase 4 | 2023-03-17 |
| Active Not Recruiting | TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribut Liver Cancer | N/A | 2023-03-14 |
| Terminated | Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase I Sleep | Phase 2 / Phase 3 | 2023-03-01 |
| Terminated | Vapocoolant Analgesia for Breast Lymphoscintigraphy Breast Cancer | N/A | 2023-03-01 |
| Withdrawn | A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alteratio Brain Tumor | Phase 1 | 2023-02-27 |
| Active Not Recruiting | A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer Breast Carcinoma | Phase 2 | 2023-02-27 |
| Withdrawn | A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhib Hepatocellular Carcinoma, Liver Cancer | Phase 2 | 2023-02-24 |
| Recruiting | Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Re Lymphoma | N/A | 2023-02-23 |
| Recruiting | Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases Melanoma (Skin) | Phase 2 | 2023-02-23 |
| Recruiting | Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carci Metastatic Malignancy | Phase 1 / Phase 2 | 2023-02-23 |
| Recruiting | Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation So Liver Ablation, Hepatic | N/A | 2023-02-21 |
| Active Not Recruiting | A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy Pulmonary, Lung | N/A | 2023-02-10 |
| Active Not Recruiting | Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HE Breast Cancer | Phase 1 | 2023-02-09 |
| Completed | Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status Non-small Cell Lung Cancer | — | 2023-02-09 |
| Active Not Recruiting | Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Renal Cell Carcinoma | Phase 1 / Phase 2 | 2023-02-09 |
| Active Not Recruiting | The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study Cancer | — | 2023-01-30 |
| Recruiting | Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients Mantle Cell Lymphoma, Non Hodgkin Lymphoma, Hematologic Malignancy | Phase 2 | 2023-01-25 |
| Recruiting | REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) Lung Cancer | Phase 2 | 2023-01-10 |
| Recruiting | Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock O Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection | Phase 1 | 2023-01-06 |
| Terminated | Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patien Multiple Myeloma | Phase 1 | 2023-01-05 |
| Recruiting | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-na Leukemia | Phase 2 | 2022-12-20 |
| Completed | Sexual Dysfunction in Palliative Care Patients: An Assessment of Patient's Perspective Sexual Dysfunction | — | 2022-12-15 |
| Withdrawn | Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tum Tumors, Ovarian Cancer, Breast Cancer | Phase 1 | 2022-12-14 |
| Recruiting | Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) Metastatic Cancer, Cervical Cancer | Phase 2 | 2022-12-13 |
| Recruiting | The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Breast Cancer | N/A | 2022-12-05 |
| Recruiting | Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologou Myeloma Multiple | Phase 2 | 2022-12-01 |
| Recruiting | Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Casc Breast Cancer, Colorectal Cancer | N/A | 2022-11-23 |
| Recruiting | Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer Sleep, Fatigue, Anxiety | Phase 2 / Phase 3 | 2022-11-21 |
| Recruiting | Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Tel Ovarian Cancer, Breast Cancer, Colorectal Cancer | N/A | 2022-11-18 |
| Active Not Recruiting | A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Pati Lymphoma, Mantle Cell Lymphoma | EARLY_Phase 1 | 2022-11-18 |
| Terminated | Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lu Lung Cancer | N/A | 2022-11-17 |
| Recruiting | Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Co Metastases | Phase 1 | 2022-11-16 |
| Terminated | Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2022-11-16 |
| Recruiting | Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counse Li-Fraumeni Syndrome | — | 2022-11-03 |
| Recruiting | Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphod B-Cell Lymphoma, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) | Phase 1 / Phase 2 | 2022-11-01 |
| Recruiting | A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Pancreatic Cancer, Breast Cancer, Hepatocellular Carcinoma | Phase 1 | 2022-10-28 |
| Withdrawn | A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caN Cancer | Phase 2 | 2022-10-25 |
| Active Not Recruiting | Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients Glioma | N/A | 2022-10-21 |
| Active Not Recruiting | A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancrea Pancreas Cancer | Phase 1 | 2022-10-21 |
| Recruiting | A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer P Pulmonary Hemorrhage, Cancer | Phase 3 | 2022-10-14 |
| Recruiting | A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Ced Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2022-10-14 |
| Recruiting | Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quar Mycosis Fungoides | Phase 2 | 2022-10-13 |
| Recruiting | Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patien Cancer | — | 2022-10-12 |
| Recruiting | First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) f Endocrine Neoplasia | Phase 1 | 2022-10-06 |
| Recruiting | A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin' Hodgkin's Lymphoma | Phase 2 | 2022-10-05 |
| Recruiting | Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare Lung Cancer | N/A | 2022-09-29 |
| Terminated | Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers Endometrial Cancer, Ovarian Cancer | Phase 2 | 2022-09-27 |
| Withdrawn | Gallium-68 PSMA-11 PET in Participants With Prostate Cancer Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 2 | 2022-09-26 |
| Recruiting | Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma Sinonasal Melanoma, Anorectal Melanoma | Phase 2 | 2022-09-23 |
| Recruiting | Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma Recurrent Glioblastoma, Recurrent Gliosarcoma | Phase 1 / Phase 2 | 2022-09-23 |
| Recruiting | A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacit Myelodysplastic Syndromes, Myeloproliferative Chronic Myelomonocytic Leukemia | Phase 2 | 2022-09-23 |
| Recruiting | A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-c Large B-cell Lymphoma, Lymphoma | Phase 2 | 2022-09-23 |
| Active Not Recruiting | Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla Carcinomas, Renal Medullary Carcinoma | Phase 2 | 2022-09-22 |
| Recruiting | A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases, Renal Cell Carcinoma | Phase 2 | 2022-09-20 |
| Terminated | A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer | EARLY_Phase 1 | 2022-09-14 |
| Active Not Recruiting | Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions Head and Neck Cancer | Phase 1 | 2022-09-13 |
| Active Not Recruiting | Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazol Tumor, Metastatic Melanoma, Melanoma | Phase 1 | 2022-09-07 |
| Active Not Recruiting | A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenva Tumor, Adenocarcinoma | Phase 1 | 2022-08-31 |
| Withdrawn | The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Mo Brain Tumor | — | 2022-08-29 |
| Terminated | Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule Benign Thyroid Gland Neoplasm, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential | N/A | 2022-08-29 |
| Withdrawn | A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Breast Cancer | Phase 2 | 2022-08-25 |
| Withdrawn | Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma Squamous Cell Carcinoma, Oropharynx Cancer, Head and Neck Cancer | Phase 2 | 2022-08-24 |
| Active Not Recruiting | Impact of High Dietary Fiber on Microbiome and Vaccine Responses Influenza | N/A | 2022-08-23 |
| Completed | A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caN Pediatric ALL, Cancer | Phase 2 | 2022-08-19 |
| Terminated | Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Metastatic Breast Cancer, Breast Cancer | Phase 1 / Phase 2 | 2022-08-18 |
| Withdrawn | STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis Refractory T Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia (AML) | Phase 1 | 2022-08-16 |
| Recruiting | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Prostate Cancer | — | 2022-08-15 |